Centrica Crecimiento futuro
Future controles de criterios 0/6
CentricaSe prevé que los ingresos y beneficios de la empresa disminuyan en 12.4% y 46.1% al año, respectivamente. Se prevé que el BPA sea de decline en 42% al año. Se prevé que la rentabilidad de los fondos propios sea de 27.8% en 3 años.
Información clave
-41.4%
Tasa de crecimiento de los beneficios
-42.3%
Tasa de crecimiento del BPA
Crecimiento de los beneficios de Integrated Utilities | 7.7% |
Tasa de crecimiento de los ingresos | -10.8% |
Rentabilidad financiera futura | 14.5% |
Cobertura de analistas | Good |
Última actualización | 09 Apr 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Health Check: How Prudently Does Centrica (LON:CNA) Use Debt?
Mar 11Centrica's (LON:CNA) Attractive Earnings Are Not All Good News For Shareholders
Feb 22Subdued Growth No Barrier To Centrica plc's (LON:CNA) Price
Feb 20Is It Too Late To Consider Buying Centrica plc (LON:CNA)?
Dec 16Centrica (LON:CNA) Seems To Use Debt Quite Sensibly
Nov 28Estimating The Intrinsic Value Of Centrica plc (LON:CNA)
Nov 10What Does Centrica plc's (LON:CNA) Share Price Indicate?
Sep 16Is Centrica (LON:CNA) A Risky Investment?
Aug 20What Does The Future Hold For Centrica plc (LON:CNA)? These Analysts Have Been Cutting Their Estimates
Jul 29Are Investors Undervaluing Centrica plc (LON:CNA) By 45%?
Jul 20Centrica (LON:CNA) Has A Pretty Healthy Balance Sheet
Apr 29Analysts' Revenue Estimates For Centrica plc (LON:CNA) Are Surging Higher
Feb 18A Look At The Fair Value Of Centrica plc (LON:CNA)
Dec 25At UK£0.94, Is It Time To Put Centrica plc (LON:CNA) On Your Watch List?
Nov 28Is Centrica (LON:CNA) Using Too Much Debt?
Nov 02Centrica plc (LON:CNA) Shares Could Be 48% Below Their Intrinsic Value Estimate
Aug 22Should You Investigate Centrica plc (LON:CNA) At UK£0.82?
Jun 30We Think Centrica (LON:CNA) Is Taking Some Risk With Its Debt
Jun 15Centrica (LON:CNA) Has Some Difficulty Using Its Capital Effectively
May 08Is There An Opportunity With Centrica plc's (LON:CNA) 39% Undervaluation?
Apr 02At UK£0.78, Is It Time To Put Centrica plc (LON:CNA) On Your Watch List?
Mar 18Industry Analysts Just Upgraded Their Centrica plc (LON:CNA) Revenue Forecasts By 19%
Mar 02Here's Why Centrica (LON:CNA) Has A Meaningful Debt Burden
Dec 18Centrica (LON:CNA) Is Very Good At Capital Allocation
Nov 05What Is Centrica plc's (LON:CNA) Share Price Doing?
Sep 24These 4 Measures Indicate That Centrica (LON:CNA) Is Using Debt Extensively
Sep 03Centrica's (LON:CNA) Performance Is Even Better Than Its Earnings Suggest
Jul 30Returns On Capital Are A Standout For Centrica (LON:CNA)
Jul 16Is Centrica (LON:CNA) A Risky Investment?
Apr 20Centrica (LON:CNA) Could Become A Multi-Bagger
Mar 27How Much Did Centrica's(LON:CNA) Shareholders Earn From Share Price Movements Over The Last Five Years?
Mar 08Is Centrica plc (LON:CNA) Popular Amongst Institutions?
Feb 19Previsiones de crecimiento de beneficios e ingresos
Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
---|---|---|---|---|---|
12/31/2026 | 20,137 | 692 | 360 | 1,028 | 9 |
12/31/2025 | 20,936 | 729 | 532 | 1,086 | 9 |
12/31/2024 | 23,659 | 930 | 815 | 1,397 | 9 |
12/31/2023 | 26,458 | 3,929 | 2,417 | 2,752 | N/A |
9/30/2023 | 28,200 | 4,081 | 2,864 | 3,193 | N/A |
6/30/2023 | 29,941 | 4,232 | 3,310 | 3,634 | N/A |
3/31/2023 | 26,841 | 1,725 | 2,127 | 2,474 | N/A |
12/31/2022 | 23,741 | -782 | 943 | 1,314 | N/A |
9/30/2022 | 20,941 | -901 | 846 | 1,266 | N/A |
6/30/2022 | 18,141 | -1,021 | 749 | 1,218 | N/A |
3/31/2022 | 16,443 | -217 | 970 | 1,415 | N/A |
12/31/2021 | 14,744 | 586 | 1,191 | 1,611 | N/A |
9/30/2021 | 13,790 | 700 | 934 | 1,333 | N/A |
6/30/2021 | 12,835 | 814 | 677 | 1,055 | N/A |
3/31/2021 | 12,542 | 270 | 794 | 1,228 | N/A |
12/31/2020 | 12,249 | -274 | 911 | 1,400 | N/A |
6/30/2020 | 7,758 | -759 | 1,286 | 1,976 | N/A |
3/31/2020 | 10,376 | -861 | 890 | 1,613 | N/A |
12/31/2019 | 12,994 | -964 | 493 | 1,250 | N/A |
9/30/2019 | 22,724 | -814 | 431 | 1,243 | N/A |
6/30/2019 | 22,773 | -605 | 392 | 1,235 | N/A |
3/31/2019 | 23,039 | -211 | 700 | 1,585 | N/A |
12/31/2018 | 23,304 | 183 | 1,008 | 1,934 | N/A |
9/30/2018 | 24,570 | 354 | 840 | 1,771 | N/A |
6/30/2018 | 25,835 | 524 | 672 | 1,607 | N/A |
3/31/2018 | 26,935 | 426 | 815 | 1,724 | N/A |
12/31/2017 | 28,035 | 328 | 958 | 1,840 | N/A |
9/30/2017 | 28,028 | 447 | N/A | 1,989 | N/A |
6/30/2017 | 28,021 | 566 | N/A | 2,137 | N/A |
3/31/2017 | 27,562 | 1,119 | N/A | 2,267 | N/A |
12/31/2016 | 27,102 | 1,672 | N/A | 2,396 | N/A |
9/30/2016 | 26,501 | 512 | N/A | 2,311 | N/A |
6/30/2016 | 25,900 | -649 | N/A | 2,225 | N/A |
3/31/2016 | 26,936 | -698 | N/A | 2,211 | N/A |
12/31/2015 | 27,971 | -747 | N/A | 2,197 | N/A |
9/30/2015 | 28,541 | -621 | N/A | 1,850 | N/A |
6/30/2015 | 29,111 | -495 | N/A | 1,503 | N/A |
3/31/2015 | 29,260 | -753 | N/A | 1,360 | N/A |
12/31/2014 | 29,408 | -1,012 | N/A | 1,217 | N/A |
9/30/2014 | 29,038 | -174 | N/A | 1,900 | N/A |
6/30/2014 | 28,668 | 664 | N/A | 2,583 | N/A |
3/31/2014 | 27,620 | 807 | N/A | 2,762 | N/A |
12/31/2013 | 26,571 | 950 | N/A | 2,940 | N/A |
9/30/2013 | 26,094 | 1,019 | N/A | 3,070 | N/A |
6/30/2013 | 25,616 | 1,088 | N/A | 3,199 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. tasa de ahorro: CNASe prevé que los beneficios de la empresa disminuyan en los próximos 3 años (-46.1% al año).
Beneficios frente mercado: CNASe prevé que los beneficios de la empresa disminuyan en los próximos 3 años (-46.1% al año).
Beneficios de alto crecimiento: CNASe prevé que los beneficios de la empresa disminuyan en los próximos 3 años.
Ingresos vs. Mercado: CNASe prevé que los ingresos de la empresa disminuyan en los próximos 3 años (-12.4% al año).
Ingresos de alto crecimiento: CNASe prevé que los ingresos de la empresa disminuyan en los próximos 3 años (-12.4% al año).
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
Futura rentabilidad financiera (ROE): CNASe prevé que la Rentabilidad de los fondos propios de la empresa sea baja dentro de 3 años (14.7%).